IMCD, a global leading distribution partner and formulator of speciality chemicals and ingredients, has recently signed an agreement to acquire the business of the food and nutraceutical ingredient distributor: Daoqin Biological Technology (Shanghai) Co., Ltd., Longyu International Trade (Shanghai) Co., Ltd. and Long’en Biotechnology (Guangzhou) Co., Ltd. in China (jointly known as Daoqin).
Established in 2011, Daoqin specialises in the distribution of functional nutrition, nutraceutical and food ingredients. Daoqin represents leading suppliers and offers, through its dedicated technical team and its laboratory, innovative solutions to its customers in the food, personal care and pharmaceutical industries. Daoqin is headquartered in Shanghai, China with sales revenue of Rmb 122 million (US$16.78 million).
Nicky Huang, Managing Director of IMCD China said, “The addition of Daoqin marks another step in our journey to deepen our presence in the food and nutrition markets and broadens the scope of our life science business portfolio. We are very excited to welcome a very engaged and talented team and leverage our complementary portfolios and technical expertise to enhance our capabilities and offering in the local market.”
Jack Ning, General Manager of Daoqin said, “The Daoqin team is excited to join IMCD, as we believe there are strong synergies between our businesses and capabilities. By leveraging IMCD’s exceptional global network and resources, we look forward to bringing greater innovation and value to customers in the life sciences markets in China.”
For more information, click on: IMCD Asia Pte Ltd